Cancer Immunoprevention Network

The Cancer Immunoprevention Network (CIP-Net), established by the National Cancer Institute (NCI), advances the understanding of fundamental immunoprevention mechanisms, drives the discovery of novel strategies, and supports the preclinical development and testing of new interventions. More info: nci-cipnet.org

📢 Published in @NatureProtocols , this new tutorial from @NIH researchers provides a practical roadmap for integrating frontier large language models (LLMs) into healthcare. From selecting the right model and prompt engineering to fine-tuning, deployment, and responsible implementation, it offers step-by-step guidance to help clinicians and researchers use LLMs safely, effectively, and responsibly. nature.com/articles/s4159… #HealthcareAI #AI #LLM #DigitalHealth #ClinicalResearch

NEW content online! The DNA damage response and cancer immunotherapy dlvr.it/TTl7ys

RT @NCIARTNet: 📢 Save the date! Join the 4th Annual @theNCI Office of Data Sharing Symposium, Data to Discovery: Leveraging Cancer Data in…

Register now for the upcoming NCI Office of Data Sharing Seminar Series on July 29, 2026! Join Dr. Julian Hong of @UCSF as he presents "Generalizable Multimodal AI Approaches to Advance Cancer Care Delivery." Register here: events.cancer.gov/ods/webinar/up…

Understanding how healthy cells protect themselves can reveal new ways to fight cancer. New @theNCI research identified a protein pathway that helps prevent blood stem cells from becoming leukemia—a promising step toward future treatments. go.nih.gov/ZMpXl05

The AACR-Debbie’s Dream Foundation Innovation and Discovery Grant is a two-year, $100,000 grant to support investigators examining important and druggable novel targets and/or biomarkers that are relevant to gastric cancer. Apply by July 22: brnw.ch/21x45Xp #AACRGrants

📢 Registration deadline extended! Join the 2026 #NCIDataJamboree (Nov. 16–18) to collaborate with researchers, trainees, patients, advocates, and citizen scientists using public cancer datasets to advance cancer research. Submit your project and register by July 27, 2026. events.cancer.gov/nci/datajambor… #CancerResearch #OpenScience #DataScience

One of my priorities is communicating more directly with the cancer research community. Tuesdays with Tony is a new series on NCI's LinkedIn page where I'll share my perspective on the issues shaping cancer research—and where we're headed next. linkedin.com/company/nation…

Every genetic variant tells a story—but until now, the risk associated with many BRCA2 variants has remained uncertain. New research from @theNCI classified more than 6,500 BRCA2 variants, helping lay the groundwork for more informed risk assessment. go.nih.gov/8hFTqAA

Cancer prevention starts with awareness. Skin cancer can affect people of every skin tone, yet it is often detected later in those with darker skin. Educating communities about risk factors and early detection is key to improving outcomes for all. go.nih.gov/gD4fpDk

For readers interested in mRNA therapeutics, including enzyme replacement therapies, cancer immunotherapies, genome-modifying therapies and immune cell reprogramming therapies, here's a comprehensive review nature.com/articles/s4157… rdcu.be/friiI

NCI researchers developed a new data-driven tool that uncovers previously hidden proteins linked to immunotherapy outcomes. By identifying potential therapeutic targets the tool highlights how data science can accelerate discovery and advance precision cancer treatment. go.nih.gov/SFxvEFF

Congratulations to Dr. Haval Shirwan of @MIZCOMO on being named the recipient of the 2026 Basic Science Established Investigator Award by the American Society of Transplantation (AST)! myast.org/blog/ast-congr…

What if bacteria could be programmed to find tumors and deliver cancer therapies directly where they're needed? A new @NatureCancer Perspective by Noah Chen, Zaofeng Yang, and Nicholas Arpaia @arpaialab explores the promise of engineered bacteria as living therapeutics, discussing tumor colonization, antitumor mechanisms, and strategies to improve therapeutic delivery. Read the article: rdcu.be/fmtyo #CancerResearch #Immunotherapy #SyntheticBiology #Microbiome #NatureCancer

🚨 BREAKING: A "holy grail" moment for lung cancer prevention. Funded in part by a @TheMarkFdn ASPIRE Award & published in @CellCellPress, @CharlesSwanton & team have discovered a 14-protein blood signature that can predict lung cancer risk over 5 years before a diagnosis. 🧵👇 themarkfoundation.org/portfolio/tumo…

Join the @theNCI Division of Cancer Prevention Immunology Interest Group for a special seminar presentation on Wednesday June 10 at 1pm ET. We will hear from Dr. Nicholas Arpaia @arpaialab, Associate Professor of Microbiology & Immunology at the @Columbia Herbert Irving Comprehensive Cancer Center discussing his research in: "Programmable Probiotics for Personalized Cancer Immunoprevention and Immunotherapy." Register today: go.nih.gov/QysclHR #CancerResearch #CancerPrevention

⏲️Faster clinical trial activation means faster access to innovation. During today’s #ASCO26 panel, @NCIDirector discussed the importance of aligning stakeholders, supporting cancer centers with guidance and incentives, sharing best practices, and partnering across @HHSGov.

Cancer Immunotherapy Month kicks off June 1! Join CRI for a monthlong celebration of the scientific breakthroughs, translational advances, and pioneering research continuing to push the immunotherapy field forward. #CancerResearch #Immunotherapy